Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1629
This examiner grants 43% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18261590 | POWDEROUS COMPOSITION(II) | Non-Final OA | DSM IP ASSETS B.V. |
| 18045793 | Polytherapy Modulating Cathelicidin Gene Expression Modulation for The Treatment of Alzheimer's Disease and Other Conditions | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 17793963 | THICKENER | Final Rejection | KANEKA CORPORATION |
| 17956249 | DISULFIRAM AND OTHER REDOX-RELATED COMPOSITIONS FOR BRAIN TUMORS | Non-Final OA | Texas Tech University System |
| 18579135 | METHODS FOR HAIR GROWTH | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 19067315 | COMPOSITION COMPRISING BIOSURFACTANT AND SALICYLIC ACID | Final Rejection | L'OREAL |
| 17044684 | DIETARY BUTYRATE | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 17736305 | Formulations/Compositions Comprising a BTK Inhibitor | Final Rejection | Janssen Pharmaceutica NV |
| 18053987 | INTERACTION BETWEEN QUATERNARY COMPOUNDS AND ANIONIC SURFACTANTS - FOAM ENHANCEMENT AND STABILIZATION AND PREFERRED FOAMING ANTIMICROBIAL COMPOSITIONS | Non-Final OA | ECOLAB USA INC. |
| 17248254 | REDUCED INHALATION HAZARD OF QUATERNARY AMMONIUM COMPOUNDS-PH DRIVEN PHYSIOLOGICAL RESPONSE | Non-Final OA | ECOLAB USA INC. |
| 16967911 | FRAGRANCE COMPOSITIONS AND USES THEREOF | Non-Final OA | Coty Inc. |
| 18777376 | METHODS OF ORAL CONTRACEPTION BY CONTROLLED RELEASE OF DIENOGEST AND ETHYNYL ESTRADIOL | Final Rejection | CHEMO RESEARCH, S.L. |
| 18750843 | HIGH POTENCY EMULSIONS | Non-Final OA | Vertosa Inc. |
| 18745512 | MODIFIED CHOLIC ACID CONJUGATES | Final Rejection | Ultra, LLC |
| 18418121 | METHODS OF TREATING LENNOX-GASTAUT SYNDROME USING FENFLURAMINE | Non-Final OA | ZOGENIX INTERNATIONAL LIMITED |
| 18418133 | METHODS OF TREATING LENNOX-GASTAUT SYNDROME USING FENFLURAMINE | Non-Final OA | ZOGENIX INTERNATIONAL LIMITED |
| 17107099 | COMBINATION THERAPY OF LYMPHOMA | Final Rejection | Universität Heidelberg |
| 18268726 | OIL BALM CLEANSING COSMETIC COMPOSITION | Non-Final OA | L V M H RECHERCHE |
| 18398952 | Rapid Onset Therapeutic Anti-Depression Ketosis Enabled by D-BetaHydroxyButyric Acid Systems, Methods and Compounds for Psilocybin co-administration | Non-Final OA | American Ketone Therapeutics LLC |
| 18390537 | Methods of Administering Myosin Inhibitors | Final Rejection | MYOKARDIA, INC. |
| 18541391 | ANTICOAGULANT REVERSAL AGENTS | Non-Final OA | COVIS Pharma GmbH |
| 17682822 | ANTIVIRAL EFFECTS OF NARASIN IN SWINE FEED | Final Rejection | Elanco US Inc. |
| 18499940 | BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | Final Rejection | ASTEX THERAPEUTICS LIMITED |
| 18460648 | METHODS OF TREATING HYPERSENSITIVE COUGH OR ITCHING USING ION CHANNEL INHIBITORY COMPOUNDS | Final Rejection | AFASCI, Inc. |
| 18447040 | THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USE THEREOF | Non-Final OA | Tvardi Operating Company, Inc. |
| 17778216 | USE OF A COMPOUND OF 4-(3-ETHOXY-4-HYDROXYPHENYL) ALKYL KETONE TYPE AGAINST BACTERIA OF THE BURKHOLDERIA CEPACIA COMPLEX | Non-Final OA | L’OREAL |
| 15939329 | ADMINISTRATION OF TAILORED FEEDSTOCK TO INCREASE ANTIBIOTIC SUSCEPTIBILITY | Non-Final OA | U.S. Army Research Laboratory |
| 15734781 | CELLULAR RETINOID BINDING PROTEIN ANTAGONISTS AND USES THEREOF | Non-Final OA | CASE WESTERN RESRVE UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy